Table 5.
In vivo | In vitro | |||
---|---|---|---|---|
Pro-/anti-fibrotic | Expression in intestinal fibrosis | mRNA | Protein | |
Th-1 cytokines | ||||
IFN-γ | Anti-fibrotic | ↑ MMP-1; ↔ MMP-9 and TIMP-1 |
||
TNF-α | Pro-fibrotic | ↑ MMP-1; ↔ MMP-9 and TIMP-1 |
↑ MMP-1 | |
Th-2 cytokines | ||||
IL-4 | Pro-fibrotic | Not studied | ↑ MMP-1; ↓ MMP-9 | |
IL-13 | Pro-fibrotic | ↑ muscle | ↔ MMP-1; ↓ MMP-9 | ↓ MMP-1 and -2 |
Th-17 cytokines | ||||
IL-17A | Pro-fibrotic | ↑ muscle | ↑ MMP-1; ↔ MMP-9 and TIMP-1 | ↑ MMP-1, -3, and -12 and TIMP-1 |
IL-22 | Pro-fibrotic | ↔ MMP-1 and -9 and TIMP-1 | ||
IL-23 | Pro-fibrotic | ↑ MMP-1 and -9 and TIMP-1 | ||
Treg | ||||
IL-10 | Anti-fibrotic | Not studied | ↑ MMP-1; ↔ TIMP-1 |
↑ = increased expression compared to control.
↓ = decreased expression compared to control.
↔ = similar expression compared to control.